Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
Open Access
- 15 May 1993
- Vol. 71 (10), 3119-3123
- https://doi.org/10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Adrenal cortical carcinomaCancer, 1989
- Adrenocortical CarcinomaUrologic Clinics of North America, 1989
- Adrenocortical CarcinomaCA: A Cancer Journal for Clinicians, 1987
- The treatment of adrenocortical carcinoma with o,p′-DDD: Prognostic simplications of serum level monitoringEuropean Journal of Cancer and Clinical Oncology, 1984
- Treatment of Adrenal CarcinomasArchives of Surgery, 1982
- Mitotane (o, p′-DDD)Cancer Treatment Reviews, 1980
- o,p′-DDD (mitotane) therapy of adrenal cortical carcinoma. Observations on drug dosage, toxicity, and steroid replacementCancer, 1978
- The clinical and pathologic featurfs of “non-hormonal” adrenocortical tumors.Report of twenty new cases and review of the literatureCancer, 1974
- Treatment of Adrenocortical Carcinoma with o,p'-DDDMedical Clinics of North America, 1972
- Adrenal cortical carcinomaAmerican Journal Of Medicine, 1966